Loading…
Biotin and arginine modified hydroxypropyl-β-cyclodextrin nanoparticles as novel drug delivery systems for paclitaxel
[Display omitted] •A novel biotin and arginine modified hydroxypropyl-β-cyclodextrin is synthesized.•Based on this polymer, a paclitaxel-loaded nanoparticles system is developed.•The paclitaxel-loaded nanoparticles are promising drug delivery carriers. A novel biotin and arginine modified hydroxypro...
Saved in:
Published in: | Carbohydrate polymers 2019-07, Vol.216, p.129-139 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c365t-95cef0d1566b39444cff04a64bdd37e2a262c5356c9b82a7091ba11dc28088803 |
---|---|
cites | cdi_FETCH-LOGICAL-c365t-95cef0d1566b39444cff04a64bdd37e2a262c5356c9b82a7091ba11dc28088803 |
container_end_page | 139 |
container_issue | |
container_start_page | 129 |
container_title | Carbohydrate polymers |
container_volume | 216 |
creator | Yan, Caixia Liang, Na Li, Qiang Yan, Pengfei Sun, Shaoping |
description | [Display omitted]
•A novel biotin and arginine modified hydroxypropyl-β-cyclodextrin is synthesized.•Based on this polymer, a paclitaxel-loaded nanoparticles system is developed.•The paclitaxel-loaded nanoparticles are promising drug delivery carriers.
A novel biotin and arginine modified hydroxypropyl-β-cyclodextrin (biotin-Arg(pbf)-HP-β-CD) was successfully synthesized. The hydroxyl groups of HP-β-CD on the primary faces were coupled with carboxyl groups of biotin using arginine as the functional spacer. Using biotin-Arg(pbf)-HP-β-CD as the carrier, paclitaxel (PTX)-loaded nanoparticles were developed by modified emulsion solvent evaporation method. The optimized PTX-loaded biotin-Arg(pbf)-HP-β-CD nanoparticles had a mean diameter of 121.9 nm and zeta potential of -57.7 mV. Transmission electron microscopy (TEM) observation revealed that the nanoparticles were spherical in shape. XRD spectra confirmed the successful encapsulation of PTX. Moreover, in vitro and in vivo evaluations were performed to demonstrate the superior antitumor activity of the PTX-loaded nanoparticles. The cellular uptake study demonstrated the biotin receptor-mediated endocytosis of biotin-Arg(pbf)-HP-β-CD nanoparticles and the increase of cellular uptake by introduction of biotin and arginine. It can be concluded that the biotin-Arg(pbf)-HP-β-CD nanoparticles are efficient tumor-targeting drug delivery systems for PTX. |
doi_str_mv | 10.1016/j.carbpol.2019.04.024 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2229236868</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0144861719304084</els_id><sourcerecordid>2229236868</sourcerecordid><originalsourceid>FETCH-LOGICAL-c365t-95cef0d1566b39444cff04a64bdd37e2a262c5356c9b82a7091ba11dc28088803</originalsourceid><addsrcrecordid>eNqFkEGO1DAQRS0EYnoGjgDykk1C2XEcZ4VgBAzSSGxgbTl2ZXDLsYOdbnWuxUE4Exl1w5ba1Ob9-qpHyCsGNQMm3-5ra_Iwp1BzYH0NogYunpAdU11fsUaIp2QHTIhKSdZdketS9rCNZPCcXDUMRAei35HjB58WH6mJjpr84KOPSKfk_OjR0R-ry-m0zjnNa6h-_6rsakNyeFrylokmptnkxduAhZpCYzpioC4fHqjD4I-YV1rWsuBU6JgynY0NfjEnDC_Is9GEgi8v-4Z8__Tx2-1ddf_185fb9_eVbWS7VH1rcQTHWimHphdC2HEEYaQYnGs65IZLbtumlbYfFDcd9GwwjDnLFSiloLkhb853txd-HrAsevLFYggmYjoUzTnveSOVVBvanlGbUykZRz1nP5m8agb6Ubne64ty_ahcg9Cb8i33-lJxGCZ0_1J_HW_AuzOA26NHj1kX6zFadD6jXbRL_j8VfwCmE5h_</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2229236868</pqid></control><display><type>article</type><title>Biotin and arginine modified hydroxypropyl-β-cyclodextrin nanoparticles as novel drug delivery systems for paclitaxel</title><source>Elsevier</source><creator>Yan, Caixia ; Liang, Na ; Li, Qiang ; Yan, Pengfei ; Sun, Shaoping</creator><creatorcontrib>Yan, Caixia ; Liang, Na ; Li, Qiang ; Yan, Pengfei ; Sun, Shaoping</creatorcontrib><description>[Display omitted]
•A novel biotin and arginine modified hydroxypropyl-β-cyclodextrin is synthesized.•Based on this polymer, a paclitaxel-loaded nanoparticles system is developed.•The paclitaxel-loaded nanoparticles are promising drug delivery carriers.
A novel biotin and arginine modified hydroxypropyl-β-cyclodextrin (biotin-Arg(pbf)-HP-β-CD) was successfully synthesized. The hydroxyl groups of HP-β-CD on the primary faces were coupled with carboxyl groups of biotin using arginine as the functional spacer. Using biotin-Arg(pbf)-HP-β-CD as the carrier, paclitaxel (PTX)-loaded nanoparticles were developed by modified emulsion solvent evaporation method. The optimized PTX-loaded biotin-Arg(pbf)-HP-β-CD nanoparticles had a mean diameter of 121.9 nm and zeta potential of -57.7 mV. Transmission electron microscopy (TEM) observation revealed that the nanoparticles were spherical in shape. XRD spectra confirmed the successful encapsulation of PTX. Moreover, in vitro and in vivo evaluations were performed to demonstrate the superior antitumor activity of the PTX-loaded nanoparticles. The cellular uptake study demonstrated the biotin receptor-mediated endocytosis of biotin-Arg(pbf)-HP-β-CD nanoparticles and the increase of cellular uptake by introduction of biotin and arginine. It can be concluded that the biotin-Arg(pbf)-HP-β-CD nanoparticles are efficient tumor-targeting drug delivery systems for PTX.</description><identifier>ISSN: 0144-8617</identifier><identifier>EISSN: 1879-1344</identifier><identifier>DOI: 10.1016/j.carbpol.2019.04.024</identifier><identifier>PMID: 31047049</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>2-Hydroxypropyl-beta-cyclodextrin - chemical synthesis ; 2-Hydroxypropyl-beta-cyclodextrin - chemistry ; 2-Hydroxypropyl-beta-cyclodextrin - toxicity ; Animals ; Antineoplastic Agents - chemistry ; Antineoplastic Agents - pharmacology ; Antineoplastic Agents - therapeutic use ; Arginine ; Arginine - analogs & derivatives ; Arginine - chemical synthesis ; Arginine - toxicity ; Biotin ; Biotin - analogs & derivatives ; Biotin - chemical synthesis ; Biotin - toxicity ; Carcinoma - drug therapy ; Drug Carriers - chemical synthesis ; Drug Carriers - chemistry ; Drug Carriers - toxicity ; Female ; Humans ; Hydroxypropyl-β-cyclodextrin ; MCF-7 Cells ; Mice ; Nanoparticles ; Nanoparticles - chemistry ; Nanoparticles - toxicity ; Paclitaxel ; Paclitaxel - chemistry ; Paclitaxel - pharmacology ; Paclitaxel - therapeutic use ; Particle Size ; Uterine Cervical Neoplasms - drug therapy ; Xenograft Model Antitumor Assays</subject><ispartof>Carbohydrate polymers, 2019-07, Vol.216, p.129-139</ispartof><rights>2019 Elsevier Ltd</rights><rights>Copyright © 2019 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c365t-95cef0d1566b39444cff04a64bdd37e2a262c5356c9b82a7091ba11dc28088803</citedby><cites>FETCH-LOGICAL-c365t-95cef0d1566b39444cff04a64bdd37e2a262c5356c9b82a7091ba11dc28088803</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31047049$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yan, Caixia</creatorcontrib><creatorcontrib>Liang, Na</creatorcontrib><creatorcontrib>Li, Qiang</creatorcontrib><creatorcontrib>Yan, Pengfei</creatorcontrib><creatorcontrib>Sun, Shaoping</creatorcontrib><title>Biotin and arginine modified hydroxypropyl-β-cyclodextrin nanoparticles as novel drug delivery systems for paclitaxel</title><title>Carbohydrate polymers</title><addtitle>Carbohydr Polym</addtitle><description>[Display omitted]
•A novel biotin and arginine modified hydroxypropyl-β-cyclodextrin is synthesized.•Based on this polymer, a paclitaxel-loaded nanoparticles system is developed.•The paclitaxel-loaded nanoparticles are promising drug delivery carriers.
A novel biotin and arginine modified hydroxypropyl-β-cyclodextrin (biotin-Arg(pbf)-HP-β-CD) was successfully synthesized. The hydroxyl groups of HP-β-CD on the primary faces were coupled with carboxyl groups of biotin using arginine as the functional spacer. Using biotin-Arg(pbf)-HP-β-CD as the carrier, paclitaxel (PTX)-loaded nanoparticles were developed by modified emulsion solvent evaporation method. The optimized PTX-loaded biotin-Arg(pbf)-HP-β-CD nanoparticles had a mean diameter of 121.9 nm and zeta potential of -57.7 mV. Transmission electron microscopy (TEM) observation revealed that the nanoparticles were spherical in shape. XRD spectra confirmed the successful encapsulation of PTX. Moreover, in vitro and in vivo evaluations were performed to demonstrate the superior antitumor activity of the PTX-loaded nanoparticles. The cellular uptake study demonstrated the biotin receptor-mediated endocytosis of biotin-Arg(pbf)-HP-β-CD nanoparticles and the increase of cellular uptake by introduction of biotin and arginine. It can be concluded that the biotin-Arg(pbf)-HP-β-CD nanoparticles are efficient tumor-targeting drug delivery systems for PTX.</description><subject>2-Hydroxypropyl-beta-cyclodextrin - chemical synthesis</subject><subject>2-Hydroxypropyl-beta-cyclodextrin - chemistry</subject><subject>2-Hydroxypropyl-beta-cyclodextrin - toxicity</subject><subject>Animals</subject><subject>Antineoplastic Agents - chemistry</subject><subject>Antineoplastic Agents - pharmacology</subject><subject>Antineoplastic Agents - therapeutic use</subject><subject>Arginine</subject><subject>Arginine - analogs & derivatives</subject><subject>Arginine - chemical synthesis</subject><subject>Arginine - toxicity</subject><subject>Biotin</subject><subject>Biotin - analogs & derivatives</subject><subject>Biotin - chemical synthesis</subject><subject>Biotin - toxicity</subject><subject>Carcinoma - drug therapy</subject><subject>Drug Carriers - chemical synthesis</subject><subject>Drug Carriers - chemistry</subject><subject>Drug Carriers - toxicity</subject><subject>Female</subject><subject>Humans</subject><subject>Hydroxypropyl-β-cyclodextrin</subject><subject>MCF-7 Cells</subject><subject>Mice</subject><subject>Nanoparticles</subject><subject>Nanoparticles - chemistry</subject><subject>Nanoparticles - toxicity</subject><subject>Paclitaxel</subject><subject>Paclitaxel - chemistry</subject><subject>Paclitaxel - pharmacology</subject><subject>Paclitaxel - therapeutic use</subject><subject>Particle Size</subject><subject>Uterine Cervical Neoplasms - drug therapy</subject><subject>Xenograft Model Antitumor Assays</subject><issn>0144-8617</issn><issn>1879-1344</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNqFkEGO1DAQRS0EYnoGjgDykk1C2XEcZ4VgBAzSSGxgbTl2ZXDLsYOdbnWuxUE4Exl1w5ba1Ob9-qpHyCsGNQMm3-5ra_Iwp1BzYH0NogYunpAdU11fsUaIp2QHTIhKSdZdketS9rCNZPCcXDUMRAei35HjB58WH6mJjpr84KOPSKfk_OjR0R-ry-m0zjnNa6h-_6rsakNyeFrylokmptnkxduAhZpCYzpioC4fHqjD4I-YV1rWsuBU6JgynY0NfjEnDC_Is9GEgi8v-4Z8__Tx2-1ddf_185fb9_eVbWS7VH1rcQTHWimHphdC2HEEYaQYnGs65IZLbtumlbYfFDcd9GwwjDnLFSiloLkhb853txd-HrAsevLFYggmYjoUzTnveSOVVBvanlGbUykZRz1nP5m8agb6Ubne64ty_ahcg9Cb8i33-lJxGCZ0_1J_HW_AuzOA26NHj1kX6zFadD6jXbRL_j8VfwCmE5h_</recordid><startdate>20190715</startdate><enddate>20190715</enddate><creator>Yan, Caixia</creator><creator>Liang, Na</creator><creator>Li, Qiang</creator><creator>Yan, Pengfei</creator><creator>Sun, Shaoping</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20190715</creationdate><title>Biotin and arginine modified hydroxypropyl-β-cyclodextrin nanoparticles as novel drug delivery systems for paclitaxel</title><author>Yan, Caixia ; Liang, Na ; Li, Qiang ; Yan, Pengfei ; Sun, Shaoping</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c365t-95cef0d1566b39444cff04a64bdd37e2a262c5356c9b82a7091ba11dc28088803</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>2-Hydroxypropyl-beta-cyclodextrin - chemical synthesis</topic><topic>2-Hydroxypropyl-beta-cyclodextrin - chemistry</topic><topic>2-Hydroxypropyl-beta-cyclodextrin - toxicity</topic><topic>Animals</topic><topic>Antineoplastic Agents - chemistry</topic><topic>Antineoplastic Agents - pharmacology</topic><topic>Antineoplastic Agents - therapeutic use</topic><topic>Arginine</topic><topic>Arginine - analogs & derivatives</topic><topic>Arginine - chemical synthesis</topic><topic>Arginine - toxicity</topic><topic>Biotin</topic><topic>Biotin - analogs & derivatives</topic><topic>Biotin - chemical synthesis</topic><topic>Biotin - toxicity</topic><topic>Carcinoma - drug therapy</topic><topic>Drug Carriers - chemical synthesis</topic><topic>Drug Carriers - chemistry</topic><topic>Drug Carriers - toxicity</topic><topic>Female</topic><topic>Humans</topic><topic>Hydroxypropyl-β-cyclodextrin</topic><topic>MCF-7 Cells</topic><topic>Mice</topic><topic>Nanoparticles</topic><topic>Nanoparticles - chemistry</topic><topic>Nanoparticles - toxicity</topic><topic>Paclitaxel</topic><topic>Paclitaxel - chemistry</topic><topic>Paclitaxel - pharmacology</topic><topic>Paclitaxel - therapeutic use</topic><topic>Particle Size</topic><topic>Uterine Cervical Neoplasms - drug therapy</topic><topic>Xenograft Model Antitumor Assays</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yan, Caixia</creatorcontrib><creatorcontrib>Liang, Na</creatorcontrib><creatorcontrib>Li, Qiang</creatorcontrib><creatorcontrib>Yan, Pengfei</creatorcontrib><creatorcontrib>Sun, Shaoping</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Carbohydrate polymers</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yan, Caixia</au><au>Liang, Na</au><au>Li, Qiang</au><au>Yan, Pengfei</au><au>Sun, Shaoping</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Biotin and arginine modified hydroxypropyl-β-cyclodextrin nanoparticles as novel drug delivery systems for paclitaxel</atitle><jtitle>Carbohydrate polymers</jtitle><addtitle>Carbohydr Polym</addtitle><date>2019-07-15</date><risdate>2019</risdate><volume>216</volume><spage>129</spage><epage>139</epage><pages>129-139</pages><issn>0144-8617</issn><eissn>1879-1344</eissn><abstract>[Display omitted]
•A novel biotin and arginine modified hydroxypropyl-β-cyclodextrin is synthesized.•Based on this polymer, a paclitaxel-loaded nanoparticles system is developed.•The paclitaxel-loaded nanoparticles are promising drug delivery carriers.
A novel biotin and arginine modified hydroxypropyl-β-cyclodextrin (biotin-Arg(pbf)-HP-β-CD) was successfully synthesized. The hydroxyl groups of HP-β-CD on the primary faces were coupled with carboxyl groups of biotin using arginine as the functional spacer. Using biotin-Arg(pbf)-HP-β-CD as the carrier, paclitaxel (PTX)-loaded nanoparticles were developed by modified emulsion solvent evaporation method. The optimized PTX-loaded biotin-Arg(pbf)-HP-β-CD nanoparticles had a mean diameter of 121.9 nm and zeta potential of -57.7 mV. Transmission electron microscopy (TEM) observation revealed that the nanoparticles were spherical in shape. XRD spectra confirmed the successful encapsulation of PTX. Moreover, in vitro and in vivo evaluations were performed to demonstrate the superior antitumor activity of the PTX-loaded nanoparticles. The cellular uptake study demonstrated the biotin receptor-mediated endocytosis of biotin-Arg(pbf)-HP-β-CD nanoparticles and the increase of cellular uptake by introduction of biotin and arginine. It can be concluded that the biotin-Arg(pbf)-HP-β-CD nanoparticles are efficient tumor-targeting drug delivery systems for PTX.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>31047049</pmid><doi>10.1016/j.carbpol.2019.04.024</doi><tpages>11</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0144-8617 |
ispartof | Carbohydrate polymers, 2019-07, Vol.216, p.129-139 |
issn | 0144-8617 1879-1344 |
language | eng |
recordid | cdi_proquest_miscellaneous_2229236868 |
source | Elsevier |
subjects | 2-Hydroxypropyl-beta-cyclodextrin - chemical synthesis 2-Hydroxypropyl-beta-cyclodextrin - chemistry 2-Hydroxypropyl-beta-cyclodextrin - toxicity Animals Antineoplastic Agents - chemistry Antineoplastic Agents - pharmacology Antineoplastic Agents - therapeutic use Arginine Arginine - analogs & derivatives Arginine - chemical synthesis Arginine - toxicity Biotin Biotin - analogs & derivatives Biotin - chemical synthesis Biotin - toxicity Carcinoma - drug therapy Drug Carriers - chemical synthesis Drug Carriers - chemistry Drug Carriers - toxicity Female Humans Hydroxypropyl-β-cyclodextrin MCF-7 Cells Mice Nanoparticles Nanoparticles - chemistry Nanoparticles - toxicity Paclitaxel Paclitaxel - chemistry Paclitaxel - pharmacology Paclitaxel - therapeutic use Particle Size Uterine Cervical Neoplasms - drug therapy Xenograft Model Antitumor Assays |
title | Biotin and arginine modified hydroxypropyl-β-cyclodextrin nanoparticles as novel drug delivery systems for paclitaxel |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T00%3A41%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Biotin%20and%20arginine%20modified%20hydroxypropyl-%CE%B2-cyclodextrin%20nanoparticles%20as%20novel%20drug%20delivery%20systems%20for%20paclitaxel&rft.jtitle=Carbohydrate%20polymers&rft.au=Yan,%20Caixia&rft.date=2019-07-15&rft.volume=216&rft.spage=129&rft.epage=139&rft.pages=129-139&rft.issn=0144-8617&rft.eissn=1879-1344&rft_id=info:doi/10.1016/j.carbpol.2019.04.024&rft_dat=%3Cproquest_cross%3E2229236868%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c365t-95cef0d1566b39444cff04a64bdd37e2a262c5356c9b82a7091ba11dc28088803%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2229236868&rft_id=info:pmid/31047049&rfr_iscdi=true |